{
     "PMID": "25982254",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160225",
     "LR": "20150606",
     "IS": "1879-1379 (Electronic) 0022-3956 (Linking)",
     "VI": "66-67",
     "DP": "2015 Jul-Aug",
     "TI": "Depressive-like behavior induced by tumor necrosis factor-alpha is attenuated by m-trifluoromethyl-diphenyl diselenide in mice.",
     "PG": "75-83",
     "LID": "10.1016/j.jpsychires.2015.04.019 [doi] S0022-3956(15)00122-3 [pii]",
     "AB": "A growing body of evidence associates activation of immune system with depressive symptoms. Accordingly, pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), have been shown to play a pivotal role in the pathophysiology of depression. The aim of this study was to evaluate the effectiveness of acute and subchronic treatments with (m-CF3-PhSe)2 to prevent the depressive-like behavior induced by intracerebroventricular injection of TNF-alpha in mice. TNF-alpha induced depressive-like behavior in the forced swimming test (FST) and tail suspension test (TST) (0.1 and 0.001 fg/5 muL/site, respectively) without changing locomotor activity, performed in the locomotor activity monitor (LAM). Acute (0.01-50 mg/kg; intragastric (i.g.); 30 min) and subchronic (0.01 and 0.1 mg/kg; i.g.; 14 days) treatments with (m-CF3-PhSe)2 at low doses were effective against the effect of TNF-alpha in the FST and TST. Nuclear factor-kappaB (NF-kappaB) and p38 mitogen-activated protein kinase (p38 MAPK), important proteins in TNF-activated signaling, were determined in the prefrontal cortex and hippocampus of mouse. TNF-alpha (0.1 fg/5 muL/site) increased NF-kappaB levels and p38 MAPK activation in both brain areas and acute (10 mg/kg; i.g.) and subchronic (0.01 mg/kg; i.g.) treatments with (m-CF3-PhSe)2 were effective in attenuating this increase. Although more studies are necessary to indicate this compound as a therapeutic alternative to depression, the antidepressant-like and anti-inflammatory effects of (m-CF3-PhSe)2 demonstrated herein may support it as an interesting molecule in the search for new drugs to treat depressive disorders that have been largely linked to immune process and inflammation.",
     "CI": [
          "Copyright (c) 2015 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Bruning, Cesar Augusto",
          "Martini, Franciele",
          "Soares, Suelen Mendonca",
          "Savegnago, Lucielli",
          "Sampaio, Tuane Bazanella",
          "Nogueira, Cristina Wayne"
     ],
     "AU": [
          "Bruning CA",
          "Martini F",
          "Soares SM",
          "Savegnago L",
          "Sampaio TB",
          "Nogueira CW"
     ],
     "AD": "Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil. Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil. Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil. Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Unidade Biotecnologia, Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil. Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil. Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil. Electronic address: criswn@ufsm.br.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150505",
     "PL": "England",
     "TA": "J Psychiatr Res",
     "JT": "Journal of psychiatric research",
     "JID": "0376331",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (NF-kappa B)",
          "0 (Organosilicon Compounds)",
          "0 (Tumor Necrosis Factor-alpha)",
          "0 (m-trifluoromethyl-diphenyl diselenide)",
          "EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents/*pharmacology",
          "Depressive Disorder/*drug therapy/physiopathology",
          "Disease Models, Animal",
          "Dose-Response Relationship, Drug",
          "Hippocampus/drug effects/metabolism",
          "Male",
          "Mice",
          "Motor Activity/drug effects/physiology",
          "NF-kappa B/metabolism",
          "Organosilicon Compounds/*pharmacology",
          "Prefrontal Cortex/drug effects/metabolism",
          "Tumor Necrosis Factor-alpha",
          "p38 Mitogen-Activated Protein Kinases/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Depression",
          "NF-kappaB",
          "Selenium",
          "TNF-alpha",
          "p38 MAPK"
     ],
     "EDAT": "2015/05/20 06:00",
     "MHDA": "2016/02/26 06:00",
     "CRDT": [
          "2015/05/19 06:00"
     ],
     "PHST": [
          "2014/08/28 00:00 [received]",
          "2015/03/17 00:00 [revised]",
          "2015/04/24 00:00 [accepted]",
          "2015/05/19 06:00 [entrez]",
          "2015/05/20 06:00 [pubmed]",
          "2016/02/26 06:00 [medline]"
     ],
     "AID": [
          "S0022-3956(15)00122-3 [pii]",
          "10.1016/j.jpsychires.2015.04.019 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Psychiatr Res. 2015 Jul-Aug;66-67:75-83. doi: 10.1016/j.jpsychires.2015.04.019. Epub 2015 May 5.",
     "term": "hippocampus"
}